Apheresis Equipment Market Massive Industry Growth Till 2024 with Asahi Kasei Bioprocess America, Inc., Terumo BCT, Fenwal, Inc., a Fresenius Kabi Company, Haemonetics, Therakos is now a part of Mallinckrodt Pharmaceuticals., HemaCare Corporation

U.S. led regional apheresis equipment market share with over 87% in 2015 and estimated to exceed USD 1,524 million by 2024. Growing demand for technologically advanced and automated products coupled with favorable reimbursement policies, and better access to advanced healthcare will drive business growth.

Europe apheresis equipment market size was over USD 365 million in 2015 and expected to surpass 1,084 million by 2024 owing to presence of less stringent apheresis devices approval regulations and availability of large untapped opportunities in emerging European countries.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/847

APAC apheresis equipment market size was valued over USD 412 million in 2015, with expectations to surpass USD 1,265 million by 2024. Rising prevalence of blood disorders in emerging markets of India and China should stimulate global apheresis equipment market share. Furthermore, improving healthcare infrastructure and rising number of healthcare practitioners should offer lucrative growth platform in this region.

Disposable apheresis kits grabbed over 78% of apheresis equipment market share in 2015, and expected to surpass USD 2,944 million by 2024 due to its growing acceptance and relatively less prices. Apheresis machines which includes membrane filtration and centrifugation should witness robust 17.1% CAGR from 2016 to 2024 due to increasing need for automated component separation devices.

Neurology held over 50% of apheresis equipment market share with over USD 863 million in 2015 witnessing a robust 12.3% CAGR over the forecast period. Indispensable need of therapeutic apheresis for treatment of neurological disorders such as multiple sclerosis and autoimmune disorders should drive the segment growth.

Browse Full Report Details @ https://www.gminsights.com/industry-analysis/apheresis-equipment-market

Plasmapheresis attributed for over 54% of apheresis equipment market share in 2015 and anticipated to exceed USD 2,152 million by 2024. Rising incidence of cardiovascular disorders coupled with growing demand for plasma derived therapies should propel plasmapheresis segment growth.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

 Asahi Kasei Bioprocess America, Inc.
 Terumo BCT
 Fenwal, Inc.
 a Fresenius Kabi Company
 Haemonetics
 Therakos is now a part of Mallinckrodt Pharmaceuticals.
 HemaCare Corporation

Increasing geriatric population base, escalating number of casualties leading to rising number of surgical procedures and growing public awareness regarding apheresis blood collection should stimulate apheresis equipment market growth. Growing demand for platelets and plasma due to rising incidence of blood related disorders, coupled with technological advancements should fuel apheresis equipment market growth. According to NHSBT, platelets demand was estimated to grow annually at 3% during 2011 to 2014 while plasma demand exceeded 20 million liters in 2010.

Favorable reimbursement policies for apheresis treatment should significantly drive apheresis equipment market share. The U.S. Government actively funds for apheresis research through benefit programs such as Medicare, Medicaid, Veterans health administration, and military and employee insurance programs. Medicare provides coverage for apheresis procedures performed in a hospital as well as in blood centers.

Disposable apheresis kits grabbed over 78% of apheresis equipment market share in 2015, and expected to surpass USD 2,944 million by 2024 due to its growing acceptance and relatively less prices. Apheresis machines which includes membrane filtration and centrifugation should witness robust 17.1% CAGR from 2016 to 2024 due to increasing need for automated component separation devices.

Neurology held over 50% of apheresis equipment market share with over USD 863 million in 2015 witnessing a robust 12.3% CAGR over the forecast period. Indispensable need of therapeutic apheresis
for treatment of neurological disorders such as multiple sclerosis and autoimmune disorders should drive the segment growth.

Plasmapheresis attributed for over 54% of apheresis equipment market share in 2015 and anticipated to exceed USD 2,152 million by 2024. Rising incidence of cardiovascular disorders coupled with growing demand for plasma derived therapies should propel plasmapheresis segment growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/847

Global apheresis equipment market share was dominated by large corporations such as Terumo, Fresenius Kabi, Haemonetics and B.Braun Melsungen. The industry is oligopolistic in nature, marked by significant number of mergers and acquisitions and strategic collaborations. Emerging countries such as China, India, and Brazil hold high future growth opportunities, hence industry participants are striving to increase their presence in these lucrative markets. The other notable industry participants include Fenwal, Therakos, Hemacare Corporation and Kawasumi Laboratories.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: http://solutionrocket.com

This release was published on openPR.